JP2022515331A5 - - Google Patents
Info
- Publication number
- JP2022515331A5 JP2022515331A5 JP2021531836A JP2021531836A JP2022515331A5 JP 2022515331 A5 JP2022515331 A5 JP 2022515331A5 JP 2021531836 A JP2021531836 A JP 2021531836A JP 2021531836 A JP2021531836 A JP 2021531836A JP 2022515331 A5 JP2022515331 A5 JP 2022515331A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024070994A JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782205P | 2018-12-19 | 2018-12-19 | |
| US62/782,205 | 2018-12-19 | ||
| US201962814707P | 2019-03-06 | 2019-03-06 | |
| US62/814,707 | 2019-03-06 | ||
| PCT/US2019/067280 WO2020132138A1 (en) | 2018-12-19 | 2019-12-18 | Multimeric t-cell modulatory polypeptides and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024070994A Division JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022515331A JP2022515331A (ja) | 2022-02-18 |
| JPWO2020132138A5 JPWO2020132138A5 (https=) | 2022-12-26 |
| JP2022515331A5 true JP2022515331A5 (https=) | 2022-12-26 |
| JP7481342B2 JP7481342B2 (ja) | 2024-05-10 |
Family
ID=71100346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531836A Active JP7481342B2 (ja) | 2018-12-19 | 2019-12-18 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
| JP2024070994A Pending JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024070994A Pending JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20220389079A1 (https=) |
| EP (1) | EP3897746A4 (https=) |
| JP (2) | JP7481342B2 (https=) |
| KR (1) | KR20210104700A (https=) |
| CN (1) | CN113286621A (https=) |
| AU (1) | AU2019401183A1 (https=) |
| BR (1) | BR112021011838A2 (https=) |
| CA (1) | CA3113096A1 (https=) |
| IL (1) | IL282250A (https=) |
| MX (1) | MX2021007479A (https=) |
| TW (1) | TWI856048B (https=) |
| WO (1) | WO2020132138A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| AU2019401183A1 (en) * | 2018-12-19 | 2021-08-12 | Cue Biopharma, Inc. | Multimeric T-cell modulatory polypeptides and methods of use thereof |
| BR112022012112A2 (pt) | 2019-12-20 | 2022-09-06 | Regeneron Pharma | Agonistas de il2 e métodos de uso dos mesmos |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| WO2022056015A1 (en) * | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides and methods of use thereof |
| EP4211149A4 (en) * | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| TW202317623A (zh) | 2021-06-14 | 2023-05-01 | 美商再生元醫藥公司 | 基於il2之治療劑及其使用方法 |
| WO2024072958A1 (en) * | 2022-09-30 | 2024-04-04 | The Children's Hospital Of Philadelphia | Systems, formulations and methods for generating universal peptide/mhc complexes with engineered disulfide connecting the heavy and light chains |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3157552T3 (pl) * | 2014-06-18 | 2020-05-18 | Albert Einstein College Of Medicine | Polipeptydy syntac i ich zastosowania |
| MY193723A (en) * | 2014-08-29 | 2022-10-27 | Hoffmann La Roche | Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1 |
| EP3322715B1 (en) * | 2015-07-14 | 2023-10-18 | BioNTech SE | Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof |
| CA3019005A1 (en) * | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) * | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| AU2019401183A1 (en) * | 2018-12-19 | 2021-08-12 | Cue Biopharma, Inc. | Multimeric T-cell modulatory polypeptides and methods of use thereof |
| CN118852456A (zh) * | 2019-05-29 | 2024-10-29 | Cue生物制药股份有限公司 | 多聚体t细胞调节多肽及其使用方法 |
| JP2022536581A (ja) * | 2019-06-19 | 2022-08-18 | キュー バイオファーマ， インコーポレイテッド | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
| WO2021081239A1 (en) * | 2019-10-23 | 2021-04-29 | Cue Biopharma, Inc. | T-cell modulatory chimeric molecules and methods of use thereof |
-
2019
- 2019-12-18 AU AU2019401183A patent/AU2019401183A1/en active Pending
- 2019-12-18 CA CA3113096A patent/CA3113096A1/en active Pending
- 2019-12-18 JP JP2021531836A patent/JP7481342B2/ja active Active
- 2019-12-18 BR BR112021011838-1A patent/BR112021011838A2/pt unknown
- 2019-12-18 KR KR1020217017809A patent/KR20210104700A/ko not_active Ceased
- 2019-12-18 EP EP19899240.6A patent/EP3897746A4/en active Pending
- 2019-12-18 WO PCT/US2019/067280 patent/WO2020132138A1/en not_active Ceased
- 2019-12-18 MX MX2021007479A patent/MX2021007479A/es unknown
- 2019-12-18 TW TW108146527A patent/TWI856048B/zh active
- 2019-12-18 CN CN201980080704.5A patent/CN113286621A/zh active Pending
-
2021
- 2021-04-12 IL IL282250A patent/IL282250A/en unknown
- 2021-05-21 US US17/327,171 patent/US20220389079A1/en not_active Abandoned
-
2024
- 2024-04-25 JP JP2024070994A patent/JP2024105344A/ja active Pending
- 2024-09-20 US US18/891,753 patent/US20250092113A1/en active Pending